Company news
SciVision Biotech Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Announcement of the approval for recordation being granted by FSC on extended offering period of the second domestic unsecured convertible bonds
August 15, 2022
Announcement of the approval for recordation being granted by FSC on extended offering period of the second domestic unsecured convertible bonds For 3 Months
August 11, 2022
Announcement of board meeting approved the consolidated financial statements for the second quarter of 2022
August 3, 2022
Announcement of the company's financial officer, accounting officer and corporate governance officer approved by Board of Directors.
June 29, 2022
SciVision Biotech Announce the record date for cash dividend
June 29, 2022
Announcement the Important Resolutions in 2022 Annual General Meeting of Shareholders
June 29, 2022
The Company’s Product, hyaluronic acid Flexotron Forte (1%) has obtained medical device license.
June 9, 2022
The The Company’s Product, hyaluronic acid three-injection linear intra-articular implant, Flexotron Plus (2%) has obtained medical device license.
May 26, 2022
The Company's Board of Directors resolved the dividend distributions
March 23, 2022
Board of Directors approved the convening of the 2022 Annual Shareholders' Meeting
March 23, 2022
The Company's 2021 consolidated financial statements have been approved by the Board of Directors
March 23, 2022
Decks
- Investor Conference 2023
Conference · 34 slides · Aug 9, 2023